Indications
INDICATION

IMDELLTRA® (tarlatamab-dlle) is indicated for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy. …READ MORE

INDICATION

IMDELLTRA® (tarlatamab-dlle) is indicated for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.

This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

Connect with an IMDELLTRA® representative

Do you have questions about IMDELLTRA® treatment?

Enter your information today and a representative will be in touch with you soon.


All fields are required unless indicated as optional.

This is not a valid email.
This is not a valid phone number.
This is not a valid address.
Alternate Address found. Please select one
Entered Address
Suggested Address
Please select your Specialty
Please make a selection
Please select the checkbox to connect to the Sales Representative
Please select the checkbox
For more information about Amgen’s privacy practices, please visit www.amgen.com/privacy.

Thanks for signing up! Your request has been sent.

A representative will be in touch with you soon.

There was an error in processing your request.

Please call us at 1-800-77-AMGEN (1-800-772-6436) to complete your request.

Please call us at IMDELLTRA® to complete your request.

Thanks for signing up! Your request has been sent.

A representative will be in touch with you soon.

System Error. Please try after some time.